Latest filing published 21 Dec 2023 for Zentalis Pharmaceuticals, Inc..
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +48.9%Entry US$50.90 · Close at T+365 US$75.80
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Kevin D. Bunker: trading record in brief
This profile gathers the share dealings of Kevin D. Bunker in Zentalis Pharmaceuticals, Inc., where the filings describe the role as senior executive. In total, 129 filings cover trades dated from 7 April 2020 to 20 December 2023.
Market trades split into 1 purchase (€5,782) and 113 sales (€18.1M). Taken together, the sales exceed the purchases by €18.1M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 5 share grants. So far in 2023, the count stands at no purchases and 5 sales.
The record was last updated on 21 December 2023 with a transaction in Zentalis Pharmaceuticals, Inc. The clock since the last published purchase (25 November 2020) now reads 2,174 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Kevin D. Bunker
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 24,158 shares0Common StockSEC:0001725160-23-000203:0
- 983 shares@ US$19.910.2% of flowCommon StockSEC:0001725160-23-000180:1
- 5,085 shares@ US$19.42651.5% of flowCommon StockSEC:0001725160-23-000180:0
- 80,000 shares@ US$30.015636.8% of flowCommon StockSEC:0001725160-23-000124:0
- 6,500 shares@ US$19.981.3% of flowCommon StockSEC:0001725160-23-000031:1
- 3,807 shares@ US$20.42441.2% of flowCommon StockSEC:0001725160-23-000031:0
- 91,354 shares0Common StockSEC:0001725160-23-000020:1
- 30,000 shares0Common StockSEC:0001725160-23-000020:0
- 50,000 shares0Common StockSEC:0001725160-22-000179:0
- 5,000 shares@ US$30.002.4% of flowCommon StockSEC:0001725160-22-000159:0
- 5,000 shares@ US$30.002.4% of flowCommon StockSEC:0001725160-22-000135:0
- 3,290 shares@ US$30.011.1% of flowCommon StockSEC:0001725160-22-000133:1
- 1,710 shares@ US$30.0240.8% of flowCommon StockSEC:0001725160-22-000133:0
- 25,000 shares@ US$30.066112.1% of flowCommon StockSEC:0001725160-22-000131:0
- 300 shares@ US$32.400.1% of flowCommon StockSEC:0001725160-22-000078:1
- 100 shares@ US$33.160.0% of flowCommon StockSEC:0001725160-22-000078:2
- 4,600 shares@ US$30.37152.1% of flowCommon StockSEC:0001725160-22-000078:0
- 4,444 shares@ US$49.50Common StockSEC:0001725160-22-000063:1
- 5,556 shares@ US$48.71844.0% of flowCommon StockSEC:0001725160-22-000063:0
- 4,301 shares@ US$47.18Common StockSEC:0001725160-22-000059:1
- 1,699 shares@ US$47.99Common StockSEC:0001725160-22-000059:2
- 4,000 shares@ US$46.23382.7% of flowCommon StockSEC:0001725160-22-000059:0
- 6,343 shares@ US$48.95Common StockSEC:0001725160-22-000048:1
- 2,451 shares@ US$49.92Common StockSEC:0001725160-22-000048:2
- 406 shares@ US$50.39Common StockSEC:0001725160-22-000048:3
25 of 129 declarations